Emily Ohland

Emily Ohland currently serves as the Director of Strategy and Innovation at Argonne National Laboratory, a position held since November 2020. Prior to this role, Emily was Director at HWC from May 2014 to October 2020, contributing to corporate leadership and overall business strategy with P&L responsibility. From September 1997 to May 2014, Emily worked as a Senior Associate at Booz Allen Hamilton, where responsibilities included leading business process reengineering for FDA regulatory processes and serving as a subject matter expert on health policy projects. Emily earned a B.S. in Chemistry with a minor in Biology from the University of Maryland between 1992 and 1997.